Research ArticleOpen AccessGoogle Scholar indexed
Vaginal Colonization and Antibiotic Susceptibility Pattern of Group B <i>Streptococcus</i> Isolated from Pregnant Women in Maternité de l’Hôpital Des Soeurs de Pauvres de Bergame de Kimbanseke, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Centre Universitaire de Référence de Surveillance de la Résistance aux Antimicrobien (CURS-RAM), Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 1 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 2 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 3 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 4 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 5 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 6 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 7 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 8 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 9 Laboratory of Experimental and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
- 10 Centre Universitaire de Référence de Surveillance de la Résistance aux Antimicrobien (CURS-RAM), Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Advances in Microbiology·Volume 11 (2021)·Pages 335–341·Published 14 July 2021·DOI10.4236/aim.2021.117026
Copy link · social · email
Abstract
Group B Streptococcus (GBS) is a Gram-positive bacterium which often colonizes maternal vaginal and rectal epitheliums and can be transmitted to the neonate during delivery. GBS infections may cause significant maternal and neonatal morbidity, including sepsis, pneumonia and meningitis. In Democratic Republic of Congo, few studies have been done on GBS colonization of pregnant women. This study was conducted in Kinshasa, Democratic Republic of Congo in order to determine the prevalence of GBS vaginal colonization among pregnant women at a gestational age of 35 - 37 weeks and the antibiotic susceptibility. Vaginal swabs of 104 pregnant women were inoculated onto Chromatic Strepto B medium. GBS isolates were identified by Gram staining, catalase test, blue-green colonies and confirmed to be GBS by Strepto B latex test kit. Antibiotic susceptibility test was done using the disc diffusion method. The prevalence of GBS vaginal colonization was 23.07%. Of the isolates studied 100%, 75%, 62.5%, 50% were sensitive to vancomycin, clindamycin, cefazolin, and erythromycin respectively. Our findings seem to suggest that maternal GBS colonization rate in this study was higher compared to a previous report from Bukavu in Democratic Republic of Congo. All isolates were found to be sensitive to vancomycin which was the most effective antibiotic for the treatment of GBS infections.
KeywordsGroup B <i>Streptococcus</i>GBS PrevalenceAntibiotic SusceptibilityDemocratic Republic of Congo
- Raabe, V.N. and Shane, A.L. (2019) Group B Streptococcus (Streptococcus agalactiae). Microbiology Spectrum, 7. https://doi.org/10.1128/microbiolspec.GPP3-0007-2018
- Rosen, G.H., et al. (2017) Group B Streptococcus and the Vaginal Microbiota. The Journal of Infectious Diseases, 216, 744-751. https://doi.org/10.1093/infdis/jix395
- Nishihara, Y., Dangor, Z., French, N., Madhi, S. and Heyderman, R. (2017) Challenges in Reducing Group B Streptococcus Disease in African Settings. Archives of Disease in Childhood, 102, 72-77. https://doi.org/10.1136/archdischild-2016-311419
- Baker, C.J. and Barrett, F.F. (1973) Transmission of Group B Streptococci among Parturient Women and Their Neonates. The Journal of Pediatrics, 83, 919-925. https://doi.org/10.1016/S0022-3476(73)80524-4
- Centers for Disease Control and Prevention (2010) Prevention of Perinatal Group B Streptococcal Disease. Morbidity and Mortality Weekly Report, 19, 1e36.
- Schrag, S.J., et al. (2002) A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates. The New England Journal of Medicine, 347, 233-239. https://doi.org/10.1056/NEJMoa020205
- López Sastre, J.B., et al. (2005) Trends in the Epidemiology of Neonatal Sepsis of Vertical Transmission in the Era of Group B Streptococcal Prevention. Acta Paediatrica, 94, 451-457. https://doi.org/10.1111/j.1651-2227.2005.tb01917.x
- Capan, M., et al. (2012) Epidemiology and Management of Group B Streptococcal Colonization during Pregnancy in Africa. Wiener Klinische Wochenschrift, 124, 14-16. https://doi.org/10.1007/s00508-012-0239-5
- Subramaniam, A., et al. (2019) Prevalence of Group B Streptococcus Anogenital Colonization and Feasibility of an Intrapartum Screening and Antibiotic Prophylaxis Protocol in Cameroon, Africa. International Journal of Gynecology & Obstetrics, 146, 238-243. https://doi.org/10.1002/ijgo.12870
- Belard, S., et al. (2015) Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa. Scientific Reports, 5, Article No. 17281. https://doi.org/10.1038/srep17281
- Bolukaoto, J.Y., et al. (2015) Antibiotic Resistance of Streptococcus agalactiae Isolated from Pregnant Women in Garankuwa, South Africa. BMC Research Notes, 8, Article No. 364. https://doi.org/10.1186/s13104-015-1328-0
- Mitima, K.T., et al. (2014) Prevalence of Colonization by Streptococcus agalactiae among Pregnant Women in Bukavu, Democratic Republic of the Congo. The Journal of Infection in Developing Countries, 8, 1195-1200. https://doi.org/10.3855/jidc.5030